In this study we investigated the effects of variously derived sources of low-dose caffeine on mood/arousal and cognitive performance. Twenty-two participants (15 men, 7 women; M age: 28.2, SD = 9.0 years) undertook five randomized, crossover trials in which they consumed either a water control (CON) or 80 mg of caffeine from one of four sources (coffee [COF], energy drink [END], capsule [CAP], and dissolvable mouth strip [STR]). We measured the participants’ perceived efficacy of these varied caffeine sources pre-treatment; and we measured mood/arousal at pre-treatment, and again at 15 and 45 minutes post-treatment. We also measured choice reaction-time at 15 and 45 minutes post-treatment, and participants completed the psychomotor vigilance task (PVT) 45 minutes post-treatment. Caffeine increased participant ratings of alertness and decreased their ratings of tiredness irrespective of source ( p’s < .05), and all sources of caffeine decreased reaction time on the PVT ( p’s < .05), with ex-Gaussian distributional analysis localizing this to the tau-parameter, indicating lower variability. However, only the COF source was associated with improved ‘overall mood’ ( p’s < .05). Participants expected to perform better on the PVT with COF compared to CON, but there were no other significant associations between source expectancy and performance. In sum, a modest dose of caffeine, regardless of source, positively impacted mood/arousal and cognitive performance, and these effects did not appear to be influenced by expectations.

This study aimed to determine if belief in caffeine's ergogenic potential influences choice reaction time (CRT) and/or running performance. Twenty-nine healthy individuals (23.7 ± 5 years, 16 males) completed two trials (one week apart). Before the trials, participants indicated their "belief" in caffeine's ergogenic effects and previous "experience" using caffeine for performance. On arrival, participants randomly received either sham "Low (100mg; LD)" or "High (300mg; HD)" dose caffeine capsules 30-min before commencing the CRT test, followed by a 10km run.Paired samples t-tests determined differences between trials for CRT latency (Ex-Gaussian analysis; μ-, σ-and τ-) and running performance using the entire cohort and sub-groups exhibiting strong "beliefs"+/−"experience". Sham caffeine dose did

Objective: Research into cognitive performance during a hangover has produced equivocal findings. This study investigated the reliability of inducing hangover symptoms and effects on cognitive performance (including applied tasks) under standardised conditions.Method: Twenty-one participants (13 M; 24 ± 3 years) completed two identical trials, involving alcohol consumption and an overnight laboratory stay. Outcome measures included: hangover severity (a single-item 'Hangover' rating, and a sum of hangover symptoms [Overall Symptoms Score (OSS)]), cognitive function (trail making test), simulated driving (standard deviation of lateral position; lane crossings), and typing performance. Spearman's correlations were used to assess reliability between trials for all participants, and when ratings of 'Hangover' were consistent.

No abstract